Therapeutic compounds and their use in treating diseases and disorders

Details for Australian Patent Application No. 2008322503 (hide)

Owner Myraid Pharmaceuticals, Inc.

Inventors Anderson, Mark B.; Markovitz, Benjamin; Shenderovich, Mark; Tangallapally, Rajendra; Bajji, Ashok C.; Trovato, Richard; Wettstein, Daniel; Kim, Se-Ho

Agent Peter Maxwell & Associates

Pub. Number AU-A-2008322503

PCT Pub. Number WO2009/065035

Priority 60/988,069 14.11.07 US

Filing date 14 November 2008

Wipo publication date 22 May 2009

International Classifications

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/70 (2006.01) - Carbohydrates

C07D 319/12 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/065035 Priority application(s): WO2009/065035

15 December 2011 Alteration of Name

  The name of the applicant has been altered to Myrexis, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008322505-Seismic data processing

2008322502-RF ablation device with jampreventing electrical coupling member